Concepedia

Haley Barnes

HB

Statistics

Publications

8

Citations

390

H-Index

8

Active since

2021

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Broad Institute

University of North Texas Health Science Center

Dana-Farber Cancer Institute

Haley Barnes is an author at Massachusetts General Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2021–2025

8

Publications

8

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

Meagan B. Ryan, Oluwadara Coker, Alexey V. Sorokin et al. · Cell Reports · 2022 · 156 citations · Full text

, , +8

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary <i>PIK3CA</i> Mutations

Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E. Martin et al. · Cancer Discovery · 2023 · 59 citations · Full text

, , +16

Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

Jakob M. Riedl, Ferran Fece de la Cruz, Christine M. Parseghian et al. · Annals of Oncology · 2025 · 48 citations · Full text

, , +17

Sotorasib Is a Pan- <i>RAS</i> G12C Inhibitor Capable of Driving Clinical Response in <i>NRAS</i> G12C Cancers

Douglas A. Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz et al. · Cancer Discovery · 2024 · 42 citations · Full text

, , +15

TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer

Rachel O. Abelman, Bogang Wu, Haley Barnes et al. · Clinical Cancer Research · 2025 · 40 citations · Full text

, , +17

1–5 of 8